scholarly journals The ventilatory abnormalities and prognostic values of H 2 FPEF score in dyspnoeic patients with preserved left ventricle systolic function

2020 ◽  
Vol 7 (4) ◽  
pp. 1872-1879
Author(s):  
Wei‐Ming Huang ◽  
Hao‐Min Cheng ◽  
Wen‐Chung Yu ◽  
Chao‐Yu Guo ◽  
Chern‐En Chiang ◽  
...  
Keyword(s):  
Left Ventricle ◽  
Systolic Function ◽  
Left Ventricle Systolic Function

Normalization of left ventricle systolic function after resynchronization therapy in patients with dilated cardiomyopathy

2012 ◽  
Vol 158 (1) ◽  
pp. 177-179 ◽  
Author(s):  
Fernando Cabrera-Bueno ◽  
Javier Alzueta ◽  
Isabel Ruiz-Zamora ◽  
Maria J. Molina-Mora ◽  
Alberto Barrera ◽  
...  
Keyword(s):  
Left Ventricle ◽  
Dilated Cardiomyopathy ◽  
Systolic Function ◽  
Resynchronization Therapy ◽  
Left Ventricle Systolic Function

scholarly journals ASSESSMENT OF THE LEFT VENTRICLE SYSTOLIC FUNCTION WITH ULTRASOUND 2D-STRAIN TECHNOLOGY IN ARTERIAL HYPERTENSION

2016 ◽  
pp. 7-11 ◽  
Author(s):  
A. B. Khadzegova ◽  
E. N. Yuschuk ◽  
R. G. Gabitova ◽  
I. A. Sinitsina ◽  
S. V. Ivanova ◽  
...  
Keyword(s):  
Left Ventricle ◽  
Arterial Hypertension ◽  
Systolic Function ◽  
2D Strain ◽  
Left Ventricle Systolic Function

scholarly journals C-Type Natriuretic Peptide Ameliorates Lipopolysaccharide-Induced Cardiac Dysfunction in Rats with Pulmonary Arterial Hypertension

2018 ◽  
Vol 2018 ◽  
pp. 1-8
Author(s):  
Xiaowei Gao ◽  
Maoen Zhu ◽  
Yanan Cao ◽  
Yue Yang ◽  
Zhi Ye ◽  
...  
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Left Ventricle ◽  
Cardiac Function ◽  
Arterial Hypertension ◽  
Natriuretic Peptide ◽  
Cardiac Dysfunction ◽  
Systolic Function ◽  
Cgmp Level ◽  
Pulmonary Arterial ◽  
Left Ventricle Systolic Function

Lipopolysaccharide induces rapid deterioration of cardiac function in rats with pulmonary arterial hypertension. It was desired to investigate if this cardiac dysfunction could be treated by C-type natriuretic peptide. Rat pulmonary arterial hypertension was induced by intraperitoneal injection of monocrotaline. Hemodynamics and cardiac function were measured by pressure-volume (P-V) catheter before and after the rats were treated with lipopolysaccharide and C-type natriuretic peptide. Cyclic guanosine 3′,5′-monophosphate (cGMP) level was determined by enzyme-linked immunosorbent assay analysis. After the rats were injected with low-dose lipopolysaccharide, they experienced left ventricle systolic function deterioration. Administration of C-type natriuretic peptide improved hemodynamics and left ventricle systolic function. cGMP level was elevated after C-type natriuretic peptide treatment. C-type natriuretic peptide could ameliorate lipopolysaccharide-induced cardiac dysfunction and restore hemodynamic deterioration in rats with pulmonary arterial hypertension.

4.44 Left-ventricle systolic function and quality of life in permanent atrial fibrillation

2001 ◽  
Vol 8 (1) ◽  
pp. S30-S30
Author(s):  
O SOLOVYOV ◽  
D EFREMOV ◽  
E ONUCHINA ◽  
O MOCHALOVA ◽  
M CHERSTVOVA ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Atrial Fibrillation ◽  
Left Ventricle ◽  
Systolic Function ◽  
Permanent Atrial Fibrillation ◽  
Left Ventricle Systolic Function

scholarly journals Relationship between mean platelet volume and left ventricular systolic function in patients with metabolic syndrome and ST-elevation myocardial infarction

2011 ◽  
Vol 34 (6) ◽  
pp. 330 ◽  
Author(s):  
Huseyin U Yazici ◽  
Fatih Poyraz ◽  
Nihat Sen ◽  
Yusuf Tavil ◽  
Murat Turfan ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Metabolic Syndrome ◽  
Left Ventricle ◽  
Systolic Function ◽  
Left Ventricular Systolic Function ◽  
Left Ventricular ◽  
St Elevation Myocardial Infarction ◽  
Ventricular Systolic Function ◽  
St Elevation ◽  
Left Ventricle Systolic Function

Purpose: Mean platelet volume (MPV) is an indicator of platelet activation, which is a central process in the pathophysiology of coronary heart disease. Metabolic syndrome (MS) may lead to worsened left ventricular systolic function by causing recurrent thrombotic events and by aggravating systemic inflammation in the course of acute myocardial infarction. The present study was designed to investigate the relationship between MPV and left ventricular systolic function in patients with metabolic syndrome who had first ST-elevation myocardial infarction. Methods: MPV was measured on admission in 33 patients who had preserved left ventricle systolic function (mean age, 56.9±10.2 years) and in 48 patients who had depressed left ventricle systolic function (mean age, 57.9±10.5 years) with metabolic syndrome and first ST elevation myocardial infarction. Depressed left ventricle systolic function was defined as ≤50% ejection fraction value. MPV levels were compared in the two groups. Results: MPV was significantly higher in patients with depressed left ventricle systolic function in comparison with patients showing preserved left ventricle systolic function (p=0.02). Logistic regression analysis showed an independent relationship between MPV and deteriorated left ventricular systolic function, even after adjustment for potential confounders (1.08 (1.04-1.20), CI: 95%, p=0.02). Conclusions: Increased MPV on admission can be associated with degree of left ventricle systolic depression in patients with metabolic syndrome with first ST-elevation myocardial infarction. MPV may prove to be useful as a prognostic marker in patients with metabolic syndrome and ST elevation MI.

Sign in / Sign up

Export Citation Format

Share Document